Le Lézard
Classified in: Health
Subject: RCL

Advisory - RestoraLAX 45 + 10 Value Pack sold at Costco Canada recalled due to potential choking hazard


OTTAWA, July 2, 2017 /CNW/ -

Issue
Health Canada is advising Canadians that Bayer Inc. is voluntarily recalling RestoraLAX 45 + 10 Value Pack sold at Costco Canada due to a potential choking hazard. The recalled product may contain deposits such as clumps or lumps.? The presence of these deposits may pose a choking hazard.

RestoraLAX is used to relieve occasional constipation and irregularity.

Who is affected

Affected products
RestoraLAX 45 + 10 Value Pack (DIN: 02318164?)

This product is sold as a combination pack: 1 bottle of 45 Dose RestoraLAX and 1 box of 10 single dose sachets of RestoraLAX shrink wrapped together for sale by Costco Canada only.

What consumers should do

What Health Canada is doing
Health Canada is monitoring the company's recall. If new safety information is identified, Health Canada will take appropriate action and inform Canadians.

For more information
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.

Également disponible en français

 

SOURCE Health Canada


These press releases may also interest you

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...



News published on and distributed by: